IntegraGen SA (EPA:ALINT)
France · Delayed Price · Currency is EUR 0.1905
+0.0150 (8.55%)
Aug 21, 2026, 4:38 PM CET
IntegraGen Market Cap
IntegraGen has a market cap or net worth of €1.18 million as of August 21, 2026. Its market cap has decreased by -39.93% in one year.
Market Cap
1.18M
Enterprise Value
366.54K
Revenue
5.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.19
ChartMarket Cap Chart
Since June 18, 2010, IntegraGen's market cap has decreased from 34.24M to 1.18M, a decrease of -96.56%. That is a compound annual growth rate of -18.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 1.18M | 33.68% |
| Dec 31, 2025 | 880.55K | -76.46% |
| Dec 31, 2024 | 3.74M | -36.97% |
| Dec 29, 2023 | 5.93M | -25.72% |
| Dec 30, 2022 | 7.99M | 8.73% |
| Dec 31, 2021 | 7.35M | -46.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 22.68M |
| Aelis Farma | 14.41M |
| Aton | 12.59M |
| NFL Biosciences | 11.23M |
| Poxel | 10.49M |
| Biophytis | 9.62M |
| TME Pharma | 8.39M |
| Oncodesign Precision Medicine Société anonyme | 6.11M |